Abstract
A new synthetic approach for the antiglaucoma agent, travoprost (1) has been developed in four steps from key intermediate (2). Key transformations include Horner – Wadsworth – Emmons reaction and separation of diastereomers to obtain (±) travoprost (1) and its analogs.
Keywords: Prostaglandins, antiglaucoma, (±) travoprost, Phosphonate, n-BuLi, dimethyl, methane, dimethoxyethane, alkylation
Letters in Organic Chemistry
Title: Synthesis of (±) Travoprost and its Analogs
Volume: 8 Issue: 4
Author(s): Harikrishna Mudduluru, Rama M. Hindupur, Pramod K. Dubey, Shankar Madhavaram, Lakshmikumar Tatini and Gottumukkala V. Subbaraju
Affiliation:
Keywords: Prostaglandins, antiglaucoma, (±) travoprost, Phosphonate, n-BuLi, dimethyl, methane, dimethoxyethane, alkylation
Abstract: A new synthetic approach for the antiglaucoma agent, travoprost (1) has been developed in four steps from key intermediate (2). Key transformations include Horner – Wadsworth – Emmons reaction and separation of diastereomers to obtain (±) travoprost (1) and its analogs.
Export Options
About this article
Cite this article as:
Mudduluru Harikrishna, M. Hindupur Rama, K. Dubey Pramod, Madhavaram Shankar, Tatini Lakshmikumar and V. Subbaraju Gottumukkala, Synthesis of (±) Travoprost and its Analogs, Letters in Organic Chemistry 2011; 8 (4) . https://dx.doi.org/10.2174/157017811795371485
DOI https://dx.doi.org/10.2174/157017811795371485 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Discovery of New Cardiovascular Hormones for the Treatment of Congestive Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment
Current Alzheimer Research Suramin: Clinical Uses and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Adrenergic Receptors as Novel Targets for Cancer Therapy (Guest Editors: D.G. Powe and F. Entschladen)]
Current Cancer Therapy Reviews Intimal Hyperplasia in Murine Models
Current Drug Targets Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier
Current Pharmaceutical Biotechnology Neuropeptide - Adipose Tissue Communication and Intestinal Pathophysiology
Current Pharmaceutical Design Pharmacology and Therapeutic Applications of A3 Receptor Subtype
Current Topics in Medicinal Chemistry The Facilitatory Effect of Casearia sylvestris Sw. (guaçatonga) Fractions on the Contractile Activity of Mammalian and Avian Neuromuscular Apparatus
Current Pharmaceutical Biotechnology Aging in Down Syndrome and the Development of Alzheimer’s Disease Neuropathology
Current Alzheimer Research Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease
Current Pharmaceutical Design Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review
Current Medicinal Chemistry Current Advances in Retroviral Gene Therapy
Current Gene Therapy The Use of Naltrexone in Dermatology. Current Evidence and Future Directions
Current Drug Targets The Interplay between Cofilin and Phospho-Cofilin: Its Role in Maintaining Blood Brain Barrier Integrity
CNS & Neurological Disorders - Drug Targets Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Edtorial [Hot topic: Glucocorticoids from Chemistry to Clinics (Executive Editor: Fortunato Vesce)]
Current Pharmaceutical Design Antinociceptive Activities of Some 4,5-Dihydro-1H-Pyrazole Derivatives: Involvement of Central and Peripheral Pathways
Letters in Drug Design & Discovery Small Molecule Inhibitors of Stat3 Signaling Pathway
Current Cancer Drug Targets Ketamine Treatment Partly Reverses Alterations in Brain Derived- Neurotrophic Factor, Oxidative Stress and Energy Metabolism Parameters Induced by an Animal Model of Depression
Current Neurovascular Research